Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (2): 255-260. doi: 10.19723/j.issn.1671-167X.2021.02.004

Previous Articles     Next Articles

Expression of plasma Dickkopf-1 in patients with rheumatoid arthritis and its correlation with peripheral blood T cell subsets

CAO Di1,WANG Yan1,Δ(),WANG Liu-qing1,SUN Xiao-lin2,HUANG Fei3,MENG Yang1,REN Li-li1,ZHANG Xue-wu2,Δ()   

  1. 1. Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
    2. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
    3. Department of Rheumatology and Immunology,Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou, China
  • Received:2020-03-16 Online:2021-04-18 Published:2021-04-21
  • Contact: Yan WANG,Xue-wu ZHANG E-mail:wangyanh_1963@163.com;xuewulore@163.com
  • Supported by:
    National Natural Science Foundation of China(81771678);Key Scientific and Technological Project of Education Department of Henan Province(19A320016)

Abstract:

Objective: To detect the levels of Dickkopf-1 (DKK-1) in the plasma of patients with rheumatoid arthritis (RA), and to analyze their correlation with peripheral blood T cell subsets and clinical indicators. Methods: Enzyme-linked immunosorbent assay (ELISA) was used to detect plasma DKK-1 levels in 32 RA patients and 20 healthy controls, and to record the various clinical manifestations and laboratory indicators of the RA patients, and flow cytometry to detect peripheral blood T cell subsets in the RA patients (Including Treg, nTreg, aTreg, sTreg, Teff, Tfh, CD4+CD161+T, CD8+T, CD8+CD161+T cells). The plasma DKK-1 levels between the two groups were ompared, and its correlation with peripheral blood T cell subsets and clinical indicators analyzed. Results: (1) The plasma DKK-1 concentration of the RA patients was (124.97±64.98) ng/L. The plasma DKK-1 concentration of the healthy control group was (84.95±13.74) ng/L. The plasma DKK-1 level of the RA patients was significantly higher than that of the healthy control group (P<0.05), and the percentage of CD8+CD161+T cells in the peripheral blood of the RA patients was significantly higher than that of the healthy control group (P<0.05). (2) The plasma DKK-1 level was positively correlated with erythrocyte sedimentation rate (r=0.406, P=0.021),DAS28 score (r=0.372, P=0.036), immunoglobulin G(r=0.362, P=0.042), immunoglobulin A(r=0.377, P=0.033) ; it had no correlation with age, course of disease, C-reactive protein, rheumatoid factor, anti-cyclic citrullinated peptide antibody, immunoglobulin M, complement C3, complement C4, white blood cell, neutrophil ratio. (3) The plasma DKK-1 level in the RA patients was positively correlated with the percentage of peripheral blood CD161+CD8+T cells (r=0.413, P=0.019);it had no correlation with Treg, nTreg, aTreg, sTreg, Teff, Tfh, CD4+CD161+T, CD8+T cells. (4) The percentage of CD161+CD8+T cells was negatively correlated with erythrocyte sedimentation rate (r=-0.415, P=0.004), C-reactive protein (r=-0.393, P=0.007), DAS28 score(r=-0.392, P=0.007),rheumatoid factor (r=-0.535, P<0.001), anti-citrullinated protein antibody (r=-0.589, P<0.001), immunoglobulin G(r=-0.368, P=0.012) immunoglobulin M (r=-0.311, P=0.035); it had no correlation with age, disease course, immunoglobulin A, complement C3, complement C4,white blood cell,and neutrophil ratio. Conclusion: RA patients’ plasma DKK-1 levels and the percentage of CD8+CD161+T cells in T cell subsets in peripheral blood increase, which may be related to the secretion of proinflammatory cytokines in patients; DKK-1 is involved in the regulation of bone homeostasis and can be used as a marker of bone destruction in RA.

Key words: Rheumatoid arthritis, Dickkopf-1, T cells

CLC Number: 

  • R593.2

Table 1

Basic clinical data of study subjects"

Characteristics RA (n=32)
Age/years, $\bar{x} \pm s$ 63.09 ±11.07
Duration/years, M (Min, Max) 10.0 (5.0, 17.3)
ESR/(mm/h), $\bar{x} \pm s$ 47.53±22.76
CRP/(mg/L), M (Min, Max) 24.4 (7.2, 56.4)
DAS28, $\bar{x} \pm s$ 5.29±1.40
RF/(IU/mL), M (Min, Max) 350.0 (134.3, 657.5)
CCP/(U/mL), M (Min, Max) 178.8 (134.3, 230.7)
IgG/(g/L), $\bar{x} \pm s$ 14.06±3.93
IgA/(g/L), $\bar{x} \pm s$ 3.35±1.28
IgM/(g/L), $\bar{x} \pm s$ 1.37±0.70
C3/(g/L), $\bar{x} \pm s$ 0.93±0.24
C4/(g/L), $\bar{x} \pm s$ 0.18±0.08
WBC/(×109/L), $\bar{x} \pm s$ 6.61±2.33
Neu/%, $\bar{x} \pm s$ 63.92±13.15

Figure 1

Levels of plasma DKK-1 and percentage of peripheral blood CD8+CD161+T cells in RA group and healthy control group A, Plasma DKK-1 levels in RA and healthy controls; B, Percentage of CD8+CD161+T cells in peripheral blood of RA group and healthy control group.RA, rheumatoid arthritis; HC, healthy controls;DKK-1,Dickkopf-1."

Figure 2

Differences in peripheral blood T Cell subsets in DKK-1 elevated group, DKK-1 normal group, and healthy control group A,Treg percentage;B,nTreg percentage;C,aTreg percentage; D,sTreg percentage;E,Teff percentage;F,Tfh percentage; G,CD4+CD161+T cell percentage;H,CD8+T cell percentage;I,CD8+CD161+T cell percentage;HC, healthy controls; DKK-1, Dickkopf-1."

Figure 3

Correlation between plasma DKK-1 levels and peripheral blood CD8+ CD161+T cells in RA patients DKK-1,Dickkopf-1."

[1] Smolen JS, Aletaha D, Mcinnes IB. Rheumatoid arthritis[J]. Lancet, 2016,388(10055):2023-2038.
pmid: 27156434
[2] Lee GR. The balance of Th17 versus Treg cells in autoimmunity[J]. Int J Mol Sci, 2018,19(3):730.
[3] Chae WJ, Park JH, Henegariu O, et al. Membrane-bound Dickkopf-1 in Foxp3+ regulatory T cells suppresses T-cell-mediated autoimmune colitis[J]. Immunology, 2017,152(2):265-275.
pmid: 28556921
[4] Chae WJ, Ehrlich AK, Chan PY, et al. The Wnt antagonist Dickkopf-1 promotes pathological type 2 cell-mediated Inflammation[J]. Immunity, 2016,44(2):246-258.
pmid: 26872695
[5] Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2010,62(9):2569-2581.
[6] Glinka A, Wu W, Delius H, et al. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction[J]. Nature, 1998,391(6665):357-362.
pmid: 9450748
[7] Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF[J]. Mol Cancer, 2007,6(1):71.
[8] Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling[J]. Nat Med, 2007,13(2):156-163.
pmid: 17237793
[9] Gómez-Vaquero C, Martín I, Loza E, et al. Effect of osteoprotegerin and Dickkopf-related protein 1 on radiological progression in tightly controlled rheumatoid arthritis[J]. PLoS One, 2016,11(12):e0166691.
[10] Rout N. Enhanced Th1/Th17 functions of CD161+CD8+T cells in mucosal tissues of rhesus macaques[J]. PLoS One, 2016,11(6):e0157407.
pmid: 27309719
[11] Mitsuo A, Morimoto S, Nakiri Y, et al. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases[J]. Rheumatology (Oxford), 2006,45(12):1477-1484.
[12] Nicol B, Salou M, Vogel I, et al. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+T cells involved in multiple sclerosis[J]. J Autoimmun, 2018,88:61-74.
doi: 10.1016/j.jaut.2017.10.005
[1] Lu ZHANG,Xiao-hong HU,Cheng CHEN,Yue-ming CAI,Qing-wen WANG,Jin-xia ZHAO. Analysis of cervical instability and clinical characteristics in treatment-naive rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1049-1054.
[2] Liang LUO,Wen-gang HUO,Qin ZHANG,Chun LI. Clinical characteristics and risk factors of rheumatoid arthritis with ulcerative keratitis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1032-1036.
[3] Hua ZHONG,Li-ling XU,Ming-xin BAI,Yin SU. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026-1031.
[4] Xue LOU,Li LIAO,Xing-jun LI,Nan WANG,Shuang LIU,Ruo-mei CUI,Jian XU. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025.
[5] GAO Hong-yu,MENG Huan-xin,HOU Jian-xia,HUANG Bao-xin,LI Wei. Expression and distribution of calprotectin in healthy and inflamed periodontal tissues [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 744-749.
[6] ZHAO Kai,CHANG Zhi-fang,WANG Zhi-hua,PANG Chun-yan,WANG Yong-fu. Therapeutic effect of gene silencing peptidyl arginine deaminase 4 on pulmonary interstitial lesions induced by collagen-induced arthritis mice [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 235-239.
[7] Lu ZHANG,Xiao-hong HU,Qing-wen WANG,Yue-ming CAI,Jin-xia ZHAO,Xiang-yuan LIU. Population distribution and clinical characteristics in rheumatoid arthritis patients with cervical spine instability [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1034-1039.
[8] Guo TANG,Li LONG,Ya-xin HAN,Qing PENG,Jia-jun LIU,Hua SHANG. Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1029-1033.
[9] Jing-feng ZHANG,Xiu-ling YE,Meng DUAN,Xiao-li ZHOU,Zhong-qiang YAO,Jin-xia ZHAO. Clinical and laboratory characteristics of rheumatoid arthritis with positive antinuclear antibody [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1023-1028.
[10] Jia-li CHEN,Yue-bo JIN,Yi-fan WANG,Xiao-ying ZHANG,Jing LI,Hai-hong YAO,Jing HE,Chun LI. Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1040-1047.
[11] Jia-jing PENG,Tian LIU. Rheumatoid arthritis combined with pigmented villonodular synovitis: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1135-1139.
[12] Cai-nan LUO,Zheng-fang LI,Li-jun WU,Hai-juan CHEN,Chun-mei YANG,Wen-hui XU,Xiao-ling LIU,Wei TANG,Ping QIAO,Baihetiya Rena. Multicenter performance of the different classification criteria for rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 897-901.
[13] Hong ZHU,Li-juan ZHAO,Yan ZHOU,Yao CHEN. Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1003-1007.
[14] Xiao-ying ZHANG,Jia-yang JIN,Jing HE,Yu-zhou GAN,Jia-li CHEN,Xiao-zhen ZHAO,Jia-jia LIU,Xu-jie YOU,Xue LI,Jian-ping GUO,Xiao-feng LI,Jing LI,Ru LI,Zhan-guo LI. Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 439-444.
[15] Li WANG,Chao GAO,Di ZHU,Li-hong CHEN. Effect of functional exercises on patients with rheumatoid arthritis: a meta-analysis [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 991-997.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[4] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[5] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 351 -354 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 369 -373 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 377 -380 .